Inventor · disambiguated record
Thierry Passeron
Also filed as: PASSERON THIERRY
7 granted patents·7 pending applications·7 citations·filing 2007–2023
76Inventor score
Files withINST NAT SANTE RECH MED9HEARING VINCENT2HEARING VINCENT J1INSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE1Yukin Therapeutics1
Top patents by PatentIndex Score
14 records- 0177US8198244B2Regulation of skin characteristics by DICKKOPF1 (DKK1)HEARING VINCENT·Filed 2007·Granted Jun 12, 2012·4 cites·24 claims
- 0270US10983134B2Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disordersINST NAT SANTE RECH MED·Filed 2015·Granted Apr 20, 2021·1 cites·6 claims
- 0369US10632117B2GSK3B and uses thereof in the diagnostic and treatment of hypopigmentation disordersINST NAT SANTE RECH MED·Filed 2015·Granted Apr 28, 2020·1 cites·1 claims
- 0465US8946291B2Compositions and methods for treating pigmentary conditions and melanomaHEARING VINCENT J·Filed 2008·Granted Feb 3, 2015·1 cites·6 claims
- 0561US11650214B2Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disordersINST NAT SANTE RECH MED·Filed 2020·Granted May 16, 2023·0 cites·4 claims
- 0661US2025161377A1Composition comprising at least one bifidobacterium strain for the treatment of vitiligoINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0750US8476236B2Treatment of skin conditions by Dickkopf1 (DKK1)HEARING VINCENT·Filed 2012·Granted Jul 2, 2013·0 cites·24 claims
- 0849US2025026722A1Substituted quinolines as improved nf-kb-inducing kinase (nik) inhibitorsYukin Therapeutics·Filed 2022·Application pending·0 cites
- 0948US2018251763A1Compositions and Methods for Inducing Senescence in Cancer CellsINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 1047US2016208249A1Compositions and Methods for Inducing Senescence in Cancer CellsINST NAT SANTE RECH MED·Filed 2014·Application pending·0 cites
- 1146US12048693B2Substituted halo-quinoline derivatives, method of preparation and applications thereofINST NAT SANTE RECH MED·Filed 2019·Granted Jul 30, 2024·0 cites·14 claims
- 1245US2021061917A1Methods and compositions for treating vitiligoINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1343US2021079100A1Methods and compositions for treating hyperpigmentation disordersINSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2018·Application pending·0 cites
- 1429US2020181089A14-anilino-quinoline compounds as anti-cancer agentsINST NAT SANTE RECH MED·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thierry Passeron files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →